Sarepta Therapeutics, Inc. ( SRPT) - Key Metrics
SRPT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $4.23 | -$2.70 | $1.25 | $1.20 |
| 2025Q3 | $3.98 | -$1.80 | -$0.15 | -$0.43 |
| 2025Q2 | $6.24 | $2.01 | $2.67 | $2.34 |
| 2025Q1 | $7.65 | -$4.60 | -$5.99 | -$6.46 |
SRPT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -1.99 |
| 2025Q3 | ? | -2.68 |
| 2025Q2 | ? | 2.13 |
| 2025Q1 | ? | -3.47 |
SRPT
Price: $15.67
52 week price:
Earnings Per Share: 0.35 USD
P/E Ratio: 55.43
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 366531
Ebitda: -43.3 millionMarket Capitalization: 2.0 billion